Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
G & G Natural Betacarotene 15mg capsules
0906012B0BQADAC
|
G&G Beta Carotene | Betacarotene | Nutrition and Blood | No data available |
|
G & G Natural Vitamin E 400unit capsules
0906050P0CVAAAF
|
G & G Vitamin E | Vitamin E | Nutrition and Blood | No data available |
|
G & G Saccharomyces Boulardii 400mg capsules
091104000BBNXAU
|
Proprietary compound preparation BNF 0911040 | Other digestive aid preparations | Nutrition and Blood | No data available |
|
G & G Selenium 200microgram capsules
090504700BBFRBK
|
Proprietary compound preparation BNF 0905047 | Other selenium preparations | Nutrition and Blood | No data available |
|
G & G Vitamin B2 50mg capsules
0906025P0BIAABF
|
G & G Vitamin B2 | Riboflavin | Nutrition and Blood | No data available |
|
G & G Vitamin B6 100mg capsules
0906024N0CJAABE
|
G & G Vitamin B6 | Pyridoxine hydrochloride | Nutrition and Blood | No data available |
|
G & G Vitamin D3 1,000unit capsules
0906040G0DQAABH
|
G & G Colecalciferol | Colecalciferol | Nutrition and Blood | No data available |
|
G & G Vitamin D3 Plus 4,000unit capsules
0906040G0DQABEC
|
G & G Colecalciferol | Colecalciferol | Nutrition and Blood | No data available |
|
G & G Zinc citrate 15mg capsules
090504100BBITBD
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
G & G Zinc citrate 50mg capsules
090504100BBISBB
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
G.U. condom urinal 1136ml
22903409049
|
G.U. condom urinal 1136ml | Urinal Systems | Incontinence Appliances | No data available |
|
G.U. condom urinal 568ml
22903409048
|
G.U. condom urinal 568ml | Urinal Systems | Incontinence Appliances | No data available |
|
G.U. non-sterile female kipper bag 1.136 litre
22503405003
|
G.U. non-sterile female kipper bag 1.136 litre | Leg Bags | Incontinence Appliances | No data available |
|
G.U. non-sterile female kipper bag 568ml
22503405004
|
G.U. non-sterile female kipper bag 568ml | Leg Bags | Incontinence Appliances | No data available |
|
G.U. non-sterile kipper bag with box tap
22503405002
|
G.U. non-sterile kipper bag with box tap | Leg Bags | Incontinence Appliances | No data available |
|
G.U. non-sterile Ross type kipper bag
22503405001
|
G.U. non-sterile Ross type kipper bag | Leg Bags | Incontinence Appliances | No data available |
|
G.U. nylon connector
22903409043
|
G.U. nylon connector | Urinal Systems | Incontinence Appliances | No data available |
|
GA gel oral powder 20g sachets
090401000BBNLA0
|
Proprietary compound foods for special diets | Other food for special diet preparations | Nutrition and Blood | No data available |
|
GA1 Maxamaid powder
0913442A0BBAAAA
|
GA1 Maxamaid pdr disc/non ACBS protein SfI metabolic cond | Pdr disc/non ACBS protein SfI metabolic condition (0913442) | Nutrition and Blood | No data available |
|
Gabapentin 150mg/5ml oral liquid
0408010G0AAANAN
|
Gabapentin | Gabapentin | Central Nervous System | No data available |
|
Gabapentin 450mg/5ml oral liquid
0408010G0AAARAR
|
Gabapentin | Gabapentin | Central Nervous System | No data available |
|
Gabapentin 600mg tablets and Gabapentin 300mg capsules
0408010G0AAAXAX
|
Gabapentin | Gabapentin | Central Nervous System | No data available |
|
Gabapentin 600mg/5ml oral liquid
0408010G0AABBBB
|
Gabapentin | Gabapentin | Central Nervous System | No data available |
|
Gabapentin 800mg/5ml oral liquid
0408010G0AABCBC
|
Gabapentin | Gabapentin | Central Nervous System | No data available |
|
Gabbroral 250mg tablets
0504050T0BCAAAE
|
Gabbroral | Paromomycin sulfate | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.